O vs SGMO · P/E 50, rev $5.27B vs rev $57.8M
Realty Income Corporation (O) versus Sangamo Therapeutics Inc (SGMO) — a side-by-side from cached financials, not a winner call.
Realty Income Corporation (O) is a reit - retail company listed on NYSE.
Sangamo Therapeutics Inc (SGMO) is a biotechnology company listed on NASDAQ.
Latest reported O revenue for 2024-12-31 was $5.27B. Net income was $867.3M. Revenue was up 29.2% from 2023-12-31 to 2024-12-31. O currently screens at market cap $56.48B and trailing P/E 49.6.
Latest reported SGMO revenue for 2024-12-31 was $57.8M. Net income was -$97.9M. Revenue was down 67.2% from 2023-12-31 to 2024-12-31. SGMO currently screens at market cap $74.6M.
O currently screens at market cap $56.48B and trailing P/E 49.6. SGMO currently screens at market cap $74.6M.
Not investment advice. Open the O and SGMO stock pages for the full models.
Not investment advice.